Sirolimus allows calcineurin-inhibitor withdrawal in heart transplant patients with renal impairment resulting in improved renal function.

被引：0
|
作者：
Zolty, R [1 ]
Keller, KE [1 ]
Ireland, NP [1 ]
Frisk, RL [1 ]
Stepien, LD [1 ]
Lowes, BD [1 ]
Shakar, S [1 ]
Wolfel, EE [1 ]
Lindenfeld, J [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
67
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [31] Sirolimus pharmacokinetics in pediatric renal transplant patients receiving calcineurin inhibitor co-therapy
    Schachter, A
    Benfield, M
    Wyatt, R
    Grimm, P
    Fennell, R
    Herrin, J
    Lirenman, D
    McDonald, R
    Munoz-Arizpe, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 402 - 403
  • [32] Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients
    Khandhar, Sameer J.
    Shah, Hemal V.
    Shullo, Michael A.
    Zomak, Rachelle
    Navoney, Michelle
    McNamara, Dennis M.
    Kormos, Robert L.
    Toyoda, Yoshiya
    Teuteberg, Jeffrey J.
    CLINICAL TRANSPLANTATION, 2012, 26 (01) : 42 - 49
  • [33] Pharmacokinetics of sirolimus in heart transplant recipients with chronic renal impairment
    Moloney, ED
    O'Mahony, U
    Kirwan, M
    McCarthy, J
    Hurley, J
    Wood, AE
    Egan, JJ
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (05) : 1547 - 1550
  • [34] Worse renal transplant outcomes with sirolimus–mycophenolate than with calcineurin inhibitor regimens
    Henri Kreis
    Nature Clinical Practice Nephrology, 2007, 3 : 424 - 425
  • [35] Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment
    Ko, Hin Hin
    Greanya, Erica
    Lee, Tim K.
    Steinbrecher, Urs P.
    Erb, Siegfried R.
    Yoshida, Eric M.
    ANNALS OF HEPATOLOGY, 2008, 7 (04) : 376 - 380
  • [36] Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
    Helmschrott, Matthias
    Rivinius, Rasmus
    Bruckner, Thomas
    Katus, Hugo A.
    Doesch, Andreas O.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1673 - 1680
  • [37] Recovery of Renal Function in Heart Transplantation Patients After Conversion From a Calcineurin Inhibitor-Based Therapy to Sirolimus
    Ayub-Ferreira, S. M.
    Avila, M. S.
    Feitosa, F. S.
    Souza, G. E. C.
    Mangini, S.
    Marcondes-Braga, F. G.
    Issa, V. S.
    Bacal, F.
    Chizzola, P. R.
    Cruz, F. D. D.
    Bocchi, E. A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 542 - 544
  • [38] Effect of sirolimus withdrawal in patients with deteriorating renal function
    Kaplan, B
    Schold, J
    Srinivas, T
    Womer, K
    Foley, DP
    Patton, P
    Howard, R
    Meier-Kriesche, HU
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) : 1709 - 1712
  • [39] Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes
    Alvarado, A.
    Shetty, A.
    Traitanon, O.
    Leventhal, J.
    Mas, V.
    Chhabra, D.
    Matthews, J.
    Gallon, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [40] Renal recovery from calcineurin inhibitor toxicity using sirolimus in heart transplant recipients: What are the determinants of success?
    Gustafsson, Finn
    Ross, Heather J.
    Delgado, Maria S.
    Bernabeo, Gustavo
    Delgado, Diego H.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 161 - 161
12345